The Progress in Medicinal Chemistry series is a respected and
instructive source of information on the subject. It has a long
established reputation for excellent coverage of almost every facet
of medicinal chemistry. This volume includes information on the
discovery and development of Atorvastatin; the discovery of
CEP-1347/KT-7515, an JNK/SAPK pathway for the treatment of
neurodegenerative diseases such; and the discovery of second
generation Quinazolinone non-nucleoside reverse transcriptase
inhibitors of HIV-1; and molecular modeling of Opioid
receptor-Ligand complexes.
General
Imprint: |
Elsevier Science Ltd
|
Country of origin: |
United Kingdom |
Series: |
Progress in Medicinal Chemistry |
Release date: |
September 2002 |
First published: |
October 2002 |
Series editors: |
F.D. King
• A.W. Oxford
|
Dimensions: |
216 x 138 x 13mm (L x W x T) |
Format: |
Hardcover
|
Pages: |
149 |
ISBN-13: |
978-0-444-51054-9 |
Categories: |
Books >
Medicine >
Other branches of medicine >
Pharmacology >
General
|
LSN: |
0-444-51054-0 |
Barcode: |
9780444510549 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!